1. Reid IR, Gamble GD, Bolland MJ. Circulating calcium concentrations, vascular disease and mortality: a systematic review. J Intern Med 2016;279:524-540.
[CROSSREF] [PUBMED]
2. Jorde R, Sundsfjord J, Fitzgerald P, Bonaa KH. Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 1999;34:484-490.
[CROSSREF] [PUBMED]
3. Foley RN, Collins AJ, Ishani A, Kalra PA. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008;156:556-563.
[CROSSREF] [PUBMED]
4. Yu N, Donnan PT, Flynn RW, Murphy MJ, Smith D, Rudman A, et al. Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 2010;73:30-34.
[PUBMED]
5. Procopio M, Barale M, Bertaina S, Sigrist S, Mazzetti R, Loiacono M, et al. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine 2014;47:581-589.
[CROSSREF] [PUBMED] [PDF]
6. Shin S, Kim KJ, Chang HJ, Cho I, Kim YJ, Choi BW, et al. Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J 2012;33:2873-2881.
[CROSSREF] [PUBMED] [PDF]
7. Kwak SM, Kim JS, Choi Y, Chang Y, Kwon MJ, Jung JG, et al. Dietary intake of calcium and phosphorus and serum concentration in relation to the risk of coronary artery calcification in asymptomatic adults. Arterioscler Thromb Vasc Biol 2014;34:1763-1769.
[CROSSREF] [PUBMED]
8. Bolland MJ, Wang TK, van Pelt NC, Horne AM, Mason BH, Ames RW, et al. Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J Bone Miner Res 2010;25:505-512.
[CROSSREF] [PUBMED]
9. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R, et al. Serum calcium concentration and carotid artery plaque: a population-based study. J Cardiol 2002;39:151-157.
[PUBMED]
10. Rubin MR, Rundek T, McMahon DJ, Lee HS, Sacco RL, Silverberg SJ. Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis 2007;194:426-432.
[CROSSREF] [PUBMED]
11. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999;50:321-328.
[CROSSREF] [PUBMED]
12. Nilsson IL, Aberg J, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999;126:1049-1055.
[CROSSREF] [PUBMED]
13. Palmer M, Adami HO, Krusemo UB, Ljunghall S. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. Am J Epidemiol 1988;127:1031-1040.
[CROSSREF] [PUBMED] [PDF]
14. Luigi P, Chiara FM, Laura Z, Cristiano M, Giuseppina C, Luciano C, et al. Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results. Int J Endocrinol 2012;2012:408295
[CROSSREF] [PUBMED] [PMC] [PDF]
15. Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P, et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf) 2002;56:253-260.
[CROSSREF] [PUBMED]
16. Khaleeli AA, Johnson JN, Taylor WH. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes Metab Res Rev 2007;23:43-48.
[CROSSREF] [PUBMED]
17. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003;27:216-222.
[CROSSREF] [PUBMED] [PDF]
18. Neunteufl T, Heher S, Prager G, Katzenschlager R, Abela C, Niederle B, et al. Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol (Oxf) 2000;53:229-233.
[CROSSREF] [PUBMED]
19. Bernini G, Moretti A, Lonzi S, Bendinelli C, Miccoli P, Salvetti A. Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery. Metabolism 1999;48:298-300.
[CROSSREF] [PUBMED]
20. Bollerslev J, Rosen T, Mollerup CL, Nordenstrom J, Baranowski M, Franco C, et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94:2255-2261.
[CROSSREF] [PUBMED] [PDF]
21. Marz W, Seelhorst U, Wellnitz B, Tiran B, Obermayer-Pietsch B, Renner W, et al. Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality. J Clin Endocrinol Metab 2007;92:2363-2369.
[CROSSREF] [PUBMED] [PDF]
22. Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, et al. Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA 2013;309:1241-1250.
[CROSSREF] [PUBMED] [PMC]
23. Kamycheva E, Jorde R, Haug E, Sager G, Sundsfjord J. Effects of acute hypercalcaemia on blood pressure in subjects with and without parathyroid hormone secretion. Acta Physiol Scand 2005;184:113-119.
[CROSSREF] [PUBMED]
24. Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001;130:986-990.
[CROSSREF] [PUBMED]
25. Bristow SM, Gamble GD, Stewart A, Horne AM, Reid IR. Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br J Nutr 2015;114:1868-1874.
[CROSSREF] [PUBMED]
26. Billington EO, Bristow SM, Gamble GD, de Kwant JA, Stewart A, Mihov BV, et al. Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women. Osteoporos Int 2017;28:119-125.
[CROSSREF] [PUBMED] [PDF]
27. Daly R, Ebeling P, Khan B, Nowson C. Effects of calcium-vitamin D3 fortified milk on abdominal aortic calcification in older men: retrospective analysis of a 2-year randomised controlled trial. J Bone Miner Res 2009;24(Suppl 1):S65-S66.
28. Li S, Na L, Li Y, Gong L, Yuan F, Niu Y, et al. Long-term calcium supplementation may have adverse effects on serum cholesterol and carotid intima-media thickness in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2013;98:1353-1359.
[CROSSREF] [PUBMED] [PDF]
29. Anderson JJ, Kruszka B, Delaney JA, He K, Burke GL, Alonso A, et al. Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc 2016;5:e003815.
[CROSSREF] [PUBMED] [PMC]
30. House MG, Kohlmeier L, Chattopadhyay N, Kifor O, Yamaguchi T, Leboff MS, et al. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 1997;12:1959-1970.
[CROSSREF] [PUBMED]
31. Hilgard P. Experimental hypercalcaemia and whole blood clotting. J Clin Pathol 1973;26:616-619.
[CROSSREF] [PUBMED] [PMC]
32. James MF, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth 2004;18:581-586.
[CROSSREF] [PUBMED]
33. Yilmaz H. Assessment of mean platelet volume (MPV) in primary hyperparathyroidism: effects of successful parathyroidectomy on MPV levels. Endocr Regul 2014;48:182-188.
[CROSSREF] [PUBMED]
34. Bristow SM, Gamble GD, Stewart A, Kalluru R, Horne AM, Reid IR. Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial. Br J Nutr 2015;113:1585-1594.
[CROSSREF] [PUBMED]
35. Kruger MC, von Hurst PR, Booth CL, Kuhn-Sherlock B, Todd JM, Schollum LM. Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk. J Nutr Sci 2014;3:e6
[CROSSREF] [PUBMED] [PMC]
36. Bristow SM, Gamble GD, Stewart A, Horne L, House ME, Aati O, et al. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr 2014;112:1611-1620.
[CROSSREF] [PUBMED]
37. Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 2013;382:1268-1277.
[CROSSREF] [PUBMED]
38. Russo D, Miranda I, Ruocco C, Battaglia Y, Buonanno E, Manzi S, et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007;72:1255-1261.
[CROSSREF] [PUBMED]
39. Di Iorio B, Bellasi A, Russo D. INDEPENDENT Study Investigators. Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol 2012;7:487-493.
[CROSSREF] [PUBMED]
40. Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008;336:262-266.
[CROSSREF] [PUBMED] [PMC]
41. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691
[CROSSREF] [PUBMED] [PMC]
42. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007;115:846-854.
[CROSSREF] [PUBMED]
43. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011;342:d2040.
[CROSSREF] [PUBMED] [PMC]
44. Radford LT, Bolland MJ, Gamble GD, Grey A, Reid IR. Subgroup analysis for the risk of cardiovascular disease with calcium supplements. Bonekey Rep 2013;2:293
[CROSSREF] [PUBMED] [PMC]
45. Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM, et al. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res 2015;30:165-175.
[CROSSREF] [PUBMED]
46. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-323.
[CROSSREF] [PUBMED]
47. Bolland MJ, Grey A, Reid IR. Misclassification does not explain increased cardiovascular risks of calcium supplements. J Bone Miner Res 2012;27:959
[CROSSREF] [PUBMED]
48. Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, et al. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 2013;169:106-111.
[CROSSREF] [PUBMED]
49. Bolland MJ, Grey A, Avenell A, Reid IR. Calcium supplements increase risk of myocardial infarction. J Bone Miner Res 2015;30:389-390.
[CROSSREF] [PUBMED]
50. Wang L, Manson JE, Sesso HD. Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials. Am J Cardiovasc Drugs 2012;12:105-116.
[CROSSREF] [PUBMED] [PMC]
51. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-378.
[CROSSREF] [PUBMED]
52. Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis. Ann Intern Med 2016;165:856-866.
[CROSSREF] [PUBMED]
53. Reid IR, Avenell A, Grey A, Bolland MJ. Calcium intake and cardiovascular disease risk. Ann Intern Med 2017;166:684-685.
[CROSSREF]
54. Medicines and Healthcare Products Regulatory Agency (MHRA). Strontium ranelate (Protelos): risk of serious cardiac disorders. Restricted indications, new contraindications, and warnings. Drug Saf Update 2013;6:S1.
55. Wang X, Chen H, Ouyang Y, Liu J, Zhao G, Bao W, et al. Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. BMC Med 2014;12:158
[CROSSREF] [PUBMED] [PMC] [PDF]
56. Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ 2015;351:h4183
[CROSSREF] [PUBMED] [PMC]
57. Reid IR, Bristow SM, Bolland MJ. Calcium supplements: benefits and risks. J Intern Med 2015;278:354-368.
[CROSSREF] [PUBMED]
58. Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, et al. Calcium intake and risk of fracture: systematic review. BMJ 2015;351:h4580
[CROSSREF] [PUBMED] [PMC]
59. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-683.
[CROSSREF] [PUBMED]
60. Lewis JR, Zhu K, Prince RL. Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res 2012;27:719-722.
[CROSSREF] [PUBMED]
61. Bonnick S, Broy S, Kaiser F, Teutsch C, Rosenberg E, DeLucca P, et al. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Curr Med Res Opin 2007;23:1341-1349.
[CROSSREF] [PUBMED]
62. Larsson SC, Burgess S, Michaelsson K. Association of genetic variants related to serum calcium levels with coronary artery disease and myocardial infarction. JAMA 2017;318:371-380.
[CROSSREF] [PUBMED] [PMC]